MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort

    L. Smith, X. Li, A. Gill, P. Panzarasa, J. Bestwick, A. Schrag, A. Noyce, A. de Simoni (London, United Kingdom)

  • Feasibility of Reliable, Remote Assessment of a 13-year-old Boy Who Stopped Talking

    N. Kadubandi, A. Elshourbagy, J. Brašić (Baltimore, USA)

  • FGF14 repeat expansions: prevalence and case series of patients with SCA27B from Slovakia

    M. Ostrozovicova, J. Necpal, D. Pellerin, H. Lee, O. Shabatiuk, K. Kulcsarova, A. Lackova, V. Roth, M. Wandzel, MJ. Dicaire, M. Danzi, V. Han, L. Trckova, S. Zuchner, M. Rizig, H. Houlden, C. Bonnet, M. Renaud, B. Brais, M. Skorvanek (Kosice, Slovakia)

  • First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

    C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)

  • First-In-Human Single and Multiple Ascending Dose Trial Design of LY3962681, a Novel Intrathecally Delivered siRNA Targeting α-synuclein mRNA for the Treatment of Patients with Parkinson’s Disease

    T. Lewis, B. Calamini, L. Verselis, M. Lowrey, L. Shaughnessy, J. Deranick, M. Dieter, M. Krautkramer, O. Uspenskaya, J. Sevigny (New York, USA)

  • Five-Year Changes in MDS-UPDRS-III after Light Treatment (Photobiomodulation)

    B. Bicknell, S. Tilley, G. Herkes, A. Liebert (, Westmead, Australia)

  • Fixel Analysis of Diffusion Imaging in Cerebellar Tracts as a Quantitative Marker of Disease Progression in Spinocerebellar Ataxia

    D. Arpin, S. Subramony, D. Vaillancourt, M. Burns (Gainesville, USA)

  • Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO), A Novel Retinal Mitochondrial Biomarker For Parkinson’s Disease

    K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

  • Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up

    E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, I. Obeso, M. Escribano, T. Jiménez Castellanos, C. Gasca-Salas, M. Matarazzo, JA. Obeso (Madrid, Spain)

  • Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome

    J. Peters, J. Maamary, K. Kyle, I. Osborne, N. Olsen, L. Jones, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley